Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Immunohorizons|April 30, 2019
Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in MiceAngela Choi, Badiaa Bouzya, Klaus-Daniel Cortés Franco, et al.Investigative Genetics|August 8, 2014
Validation of high throughput sequencing and microbial forensics applicationsBruce Budowle, Nancy D Connell, Anna Bielecka-Oder, et al.Journal of Immunological Methods|May 24, 2015
Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapiesMaxime Hallé, Pascale Tribout-Jover, Anne-Marie Lanteigne, et al.Plos Pathogens|November 2, 2020
Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion FWayne Harshbarger, Sai Tian, Newton Wahome, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|November 15, 2017
Structural, magnetic and electronic properties of pulsed-laser-deposition grown SrFeO<sub>3-δ</sub> thin films and SrFeO<sub>3-δ</sub> /La<sub>2/3</sub>Ca<sub>1/3</sub>MnO<sub>3</sub> multilayersE Perret, K Sen, J Khmaladze, et al.NPJ Vaccines|December 17, 2019
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohortsRaffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, et al.Science Translational Medicine|August 23, 2023
The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strainsLionel Sacconnay, Jonathan De Smedt, Vera Rocha-Perugini, et al.Frontiers in Bioinformatics|August 5, 2025
Design of cross-reactive antigens with machine learning and high-throughput experimental evaluationChelsy Chesterman, Thomas Desautels, Luz-Jeannette Sierra, et al.The Lancet. Infectious Diseases|April 24, 2022
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trialNicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, et al.Biorxiv : the Preprint Server for Biology|June 26, 2025
Computationally designed stem-epitope mimetics elicit broadly reactive antibodiesSarah Wehrle, Andreas Scheck, Laura Reusch, et al.Pageof 8